Mednet Logo

Would you recommend a GLP-1 agonist as an option to reduce the risk of dementia in patients with a strong family history?

As studied in Tang H, Donahoo WT, DeKosky ST, et al. GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias. JAMA Neurol. 2025;82(5):439–449. doi:10.1001/jamaneurol.2025.0353 AND Seminer A, Mulihano A, O'Brien C, Krewer F, Costello M, Judge C, O'Donnell M, Reddin C. Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis. JAMA Neurol. 2025 May 1;82(5):450-460. doi: 10.1001/jamaneurol.2025.0360. PMID: 40193122; PMCID: PMC11976645.
Community PollStarted

Would you recommend a GLP-1 agonist as an option to reduce the risk of dementia in patients with a strong family history?

41 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Mednet MemberInvited Expert
Primary Care · Mount Sinai Doctors Medical Group
Answered on

I'm recommending GLP-1 for many things right now, but I haven't yet independently recommended it just to reduce the risk of dementia. However, if microvascular disease can contribute to vascular dementia, then there may be a benefit to better controlling diabetes with this drug.

Join for free or sign in to see the full answer